RIL
ZVRA icon

Rothschild Investment LLC’s Zevra Therapeutics ZVRA Stock Holding History

Rothschild Investment LLC’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.02K Buy
110
+55
+100% +$496 ﹤0.01% 2862
2025
Q4 		$493 Hold
55
– – ﹤0.01% 2927
2025
Q3 		$523 Sell
55
-35
-39% -$351 ﹤0.01% 2814
2025
Q2 		$793 Sell
90
-30
-25% -$243 ﹤0.01% 2577
2025
Q1 		$899 Buy
120
+35
+41% +$278 ﹤0.01% 2402
2024
Q4 		$709 Buy
85
+60
+240% +$512 ﹤0.01% 2398
2024
Q3 		$174 Hold
25
– – ﹤0.01% 2733
2024
Q2 		$123 Buy
+25
New +$118 ﹤0.01% 2666

Other funds holding ZVRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Rothschild Investment LLC's ZVRA Position: Q1 2026 in Review

Rothschild Investment LLC increased its Zevra Therapeutics (ZVRA) stake by 100% in Q1 2026, buying an estimated $496 and bringing the position to 110 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #2862.

Rothschild Investment LLC first reported a position in ZVRA in Q2 2024 and has held it in 8 quarters since. 148 funds tracked by Wall St. Rank hold ZVRA as of Q1 2026.

  • Rothschild Investment LLC held 110 shares of Zevra Therapeutics worth $1.02K as of Q1 2026.
  • Rothschild Investment LLC bought 55 Zevra Therapeutics shares in Q1 2026, an estimated $496.
  • Zevra Therapeutics made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q1 2026, its #2862 holding.
  • Rothschild Investment LLC first reported a position in Zevra Therapeutics in Q2 2024 and has held it in 8 quarters since.
  • 148 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.